New CDC Guidance on Nirsevimab Use (01/05/2024)
In the setting of increasing supply, healthcare providers should administer a single dose of nirsevimab to all infants aged less than 8 months, as well as children aged 8 through 19 months at increased risk.
For providers who continue to have limited supply, nirsevimab should be prioritized to protect infants at highest risk for severe disease. Limited opportunities remain to prevent severe RSV. It is imperative to order, use, and reorder remaining supplies of nirsevimab as soon as possible. See updated CDC nirsevimab guidance for more details. For more information about options for optimizing RSV protection for infants, refer to this resource. Reminder: New Refrigerated Pfizer COVID-19 Vaccine for 12y+
The previous Pfizer 12y+ vaccine allocations have been replaced with Pfizer’s new refrigerated 12y+ vaccine (NDC 00069-2377-10), a new presentation in a carton of 10 manufacturer-filled syringes (MFS). Providers who have the original Pfizer 12y+ vaccine on hand can and should continue to use this product until it is consumed, expired, or has been stored at 2-8°C for longer than the allowable 10 weeks. Ordering for the new product was turned on Tuesday, December 19, 2023, and any orders placed since then are shipping this week (post-holiday shipping blackouts). See the COVID-19 Vaccine Product Guide for more details. 2024 Vaccines for Children (VFC) Recertification Now Available
Annual Recertification and training is a federal requirement to maintain active status in the VFC program and receive publicly purchased vaccines. Recertification launched on December 20, 2023, and the due date is Wednesday, January 31, 2024. For more details refer to the following resources: Update: California Immunization Registry (CAIR) Quick Entry
Since the My Turn Release 46 on Wednesday, December 20, 2023, CAIR Quick Entry allows users to submit, view, and edit vaccine administration data for most vaccines to Immunization Information Systems (IIS). Users can inline upload vaccine administration data using CAIR Quick Entry (which may look similar to the existing inline upload process for vaccines in My Turn). In addition to inline submission, users can upload vaccine administration data using CSV submission. After submitting a record, select data can be edited, including Location and Vaccine Information. Reminder: COVID-19 Medications Transition to Commercial Marketplace
While previously available free of charge, patients will start to see cost-sharing and co-pays for all COVID-19 medications (like all prescribed drugs) once the U.S. Government (U.S.G.) purchased product supply has run out.
For more information please see: Upcoming Webinar Cancellations and Closures - The CDPH Immunization Updates for LHDs is cancelled on Tuesday, January 9, 2024, due to a CDPH Immunization Staff Meeting. For post-holiday updates, please attend the Immunization Updates for Providers on Friday, January 12 from 9-10:30 AM. Register here.
- In observance of Dr. Martin Luther King, Jr., Day on Monday, January 15, 2024, CDPH and the Provider Call Center will be closed.
January Ordering Cadence
For information on ordering cadence changes see the following calendars: The My Turn and myCAvax Teams Appreciate Your Feedback! Please use the Vaccine Management Feedback Form to provide feedback and suggestions for the My Turn and myCAvax platforms. Support Opportunities
CDPH Immunization Branch Updates for Providers Webinar Please attend our weekly webinars to hear updates from CDPH subject matter experts and have your questions answered. Fridays 9:00AM – 10:30 AM Archived Sessions | Provider FAQs Provider Call Center For Program information: email providercallcenter@cdph.ca.gov or call (833) 502-1245 (Monday – Friday, 8AM–5PM) myCAvax Help Desk For technical issues (password resets, etc.): email myCAvax.HD@cdph.ca.gov or call (833) 502-1245, (Monday – Friday, 8AM – 5PM, PT) System related training materials are available via the Knowledge Center in myCAvax and at EZIZ.org. My Turn Help Desk |
